Home › Funds › Eversept Partners, LP › GERN
Eversept Partners, LP position in GERN
GERON CORP · Health Care
Eversept Partners, LP reported holding 18,717,422 shares of GERN (GERON CORP) in its Q2 2026 13F filing — a position valued at US$24.0M, representing 1.25% of its reported portfolio and ranking #21 among its reported holdings. Eversept Partners, LP has disclosed GERN holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's GERN position evolved
Eversept Partners, LP first disclosed a stake in GERN in Q2 2025 at 7,320,174 shares (US$10.3M). The position peaked in Q1 2026 at 18,834,883 shares, worth US$28.1M. Across 5 filings, Eversept Partners, LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 18,717,422 shares valued at US$24.0M — a reduction of -117,461 shares quarter over quarter.. Notable position changes include a 72% increase in Q3 2025 (shares fell 4% over the following quarter), a 40% increase in Q4 2025 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 7.32M | $10.32M | New |
| Q3 2025 | 12.60M | $17.26M | Add |
| Q4 2025 | 17.66M | $23.31M | Add |
| Q1 2026 | 18.83M | $28.06M | Add |
| Q2 2026 | 18.72M | $23.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GERN and 13F data
GERN (GERON CORP) is a Health Care company. 18 other funds we track also report a position in GERN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$54.8M), Soleus Capital Management, L.P. (US$54.8M), Nantahala Capital Management, LLC (US$15.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GERN
- RA CAPITAL MANAGEMENT, L.P. 42.81M sh · $54.80M · Q2 2026
- Soleus Capital Management, L.P. 42.81M sh · $54.80M · Q2 2026
- Nantahala Capital Management, LLC 12.22M sh · $15.65M · Q2 2026
- Vivo Capital, LLC 8.67M sh · $11.10M · Q2 2026
- Kynam Capital Management, LP 6.84M sh · $8.75M · Q2 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held GERN?
Eversept Partners, LP has disclosed GERN holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Eversept Partners, LP's current position in GERN?
As of Q2 2026, Eversept Partners, LP holds 18.72M shares of GERN (GERON CORP), valued at $23.96M, representing 1.25% of its reported portfolio and ranking #21.
Has Eversept Partners, LP been buying or selling GERN?
In the latest 13F filing (Q2 2026), Eversept Partners, LP reduced its position in GERN. The position peaked in Q1 2026 at 18.83M shares.
Which other funds hold GERN?
Other major institutional holders of GERN include RA CAPITAL MANAGEMENT, L.P., Soleus Capital Management, L.P., Nantahala Capital Management, LLC, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.